Travere Therapeutics, Inc. - FORM 10-K/A - XML - IDEA: XBRL DOCUMENT - July 9, 2015

Attached files

file filename
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Travere Therapeutics, Inc.t1501504_10ka.htm
EX-31.2 - EXHIBIT 31.2 - Travere Therapeutics, Inc.t1501504_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Travere Therapeutics, Inc.t1501504_ex31-1.htm
EX-32.2 - EXHIBIT 32.2 - Travere Therapeutics, Inc.t1501504_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Travere Therapeutics, Inc.t1501504_ex32-1.htm
v3.2.0.727
Label Element Value
Cash and Cash Equivalents, at Carrying Value us-gaap_CashAndCashEquivalentsAtCarryingValue  
Additional Paid-In Capital  
Shares, Issued us-gaap_SharesIssued  
Stockholder's deficit us-gaap_StockholdersEquity  
Common Stock [Member]  
Shares, Issued us-gaap_SharesIssued  
Stockholder's deficit us-gaap_StockholdersEquity  
Accumulated Deficit  
Shares, Issued us-gaap_SharesIssued  
Stockholder's deficit us-gaap_StockholdersEquity  
Receivables Due From Stockholder  
Shares, Issued us-gaap_SharesIssued  
Stockholder's deficit us-gaap_StockholdersEquity  

Travere Therapeutics, Inc. Reports